维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="Egloff AM"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Cyclin B1 and other cyclins as tumor antigens in immunosurveillance and immunotherapy of cancer显示文摘	Egloff AM Vella LA Finn OJ	2006	Cancer Res2006，66，：	1
2	Cyclin B1 and other cyclins as tumor antigens in immunosurveillance and immunotherapy of cancer显示文摘	Egloff AM VeUa LA Finn OJ	2006	Cancer Res2006，66，1：	1
3	Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma显示文摘	Koppikar P Choi SH Egloff AM	2008	Clin Cancer Res2008，14，13：	1
4	The mutational landscape of head and neck squamous cell carcinoma显示文摘	Stransky N Egloff AM Tward AD	2011	Science2011，333，6046：	1
5	Phase II study of irinotecan plus panitumumab as second-line therapy for patients with ad- vanced esophageal adenocarcinoma ( EAC ) 显示文摘	Atasoy A Yoon H Egloff AM	2010	J Clin Oncol2010，，：	1
6	Congenital cholesteatoma: pre-dictors for residual disease and hearingoutcomes 显示文摘	Stapleton AL Egloff AM Yellon RF	2012	Arch Otolar- yngol Head Neck Surg2012，138，3：	1
7	Chemokine receptor 7 (CCRT) gene expression is regulated by NF-kappaB and acti- vator protein 1 ( AP1 ) in metastatic squamous cell carcinoma of head and neck (SCCHN) 显示文摘	Mbum YK Egloff AM Walker WH	2012	J Biol Chem2012，287，5：	1
8	Challenges in EGFRvlII Detection in Head and Neck Squamous Cell Carcinoma显示文摘	Wheeler SE Egloff AM Wang L	2015	PIoS one2015，10，01：	1
9	The mutalional landseape of head and neck squamous cell careinoma显示文摘	Stransky N Egloff AM Tward AD	2011	Scienee2011，333，：	1
10	Phase I1 study of Cetuximab in combination with Cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern Cooperative Oncology Group Trial E3303 显示文摘	Egloff AM Lee JW Langer C J	2014	Clin Cancer Res2014，20，19：	1
11	Cyclin B1 and other cyclins as tumor antigens in immunosurveillance and immunotherapy of cancer显示文摘	Egloff AM Vella LA Finn OJ	2006	Cancer Res2006，66，1：	1
12	Epidermal growth factor receptortargeted molecular therapeutics for head and neck squamous cell carcinoma显示文摘	Egloff AM Grandis J	2006	Expert Opin Ther Targets2006，10，5：	1
13	The mutational landscape of head and neck squamous cell carcinoma显示文摘	Stransky N Egloff AM Tward AD	2011	Science2011，333，6046：	1
14	Cross-talk between estrogen receptor and epidermal growth factor receptor in head and neck squamous cell carcinoma显示文摘	Egloff AM Rothstein ME Seethala R	2009	Clin Cancer Res2009，15，21：	1
15	Revision septoplasty:A prospective disease-specific outcome study显示文摘	Gillman GS Egloff AM Rivera-Serrano CM		0，，：	1
16	TIM polymorphisms-- genetics and function显示文摘	Lee J Phong B Egloff AM	2011	Genes Immun2011，12，8：	1
17	Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma 显示文摘	Koppikar P Choi SH Egloff AM	2008	Clin Cancer Res2008，14，13：	1
18	Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma显示文摘	Koppikar P Choi SH Egloff AM	2008	Clin Cancer Res2008，14，：	1
19	Caspase-8 mutations in head and neck cancer confer resistance to death receptor-mediated apoptosis and enhance migration, invasion, and tumor growth 显示文摘	Li C Egloff AM Sen M	2014	Mol Oneol2014，8，7：	1
20	The mutational land- scape of head and neck squamous cell carcinoma 显示文摘	Stransky N Egloff AM Tward AD	2011	Seienee2011，333，6046：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示